PARP1 and cancer: Normothermic IPC is potentially limited by PARP expression, TGF-β1 related normoxic stabilization of HIF, the activation of downstream targets of the HRE, TGF-β1 related cancer cell EMT, PMC MMT or the development of EPS, which precludes further IPC treatments.